Departed
Laura Tadvalkar
Director
COAG ·
Hemab Therapeutics Holdings, Inc.
On May 8, 2026, Laura Tadvalkar, Ph.D., notified Hemab Therapeutics Holdings, Inc. (the “Company”) of her decision to resign as a member of the Company’s board of directors (the “Board”), effective immediately.